Marin, Nathalie

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science

interferon and immune responsesCOVID-19 Clinical Research Studies

Cited by 2,984

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Silvin, A., Chapuis, N., Dunsmore, G., Goubet, A.-G., Dubuisson, A., Derosa, L., Almire, C., Hénon, C., Kosmider, O., Droin, N., et al. (2020) · Cell

COVID-19 Clinical Research StudiesInflammation biomarkers and pathways

Cited by 834

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 734

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).

Reignier, J., Plantefeve, G., Mira, J.-P., Argaud, L., Asfar, P., Aissaoui, N., Badie, J., Botoc, N.-V., Brisard, L., Bui, H.-N., et al. (2023) · The Lancet Respiratory Medicine

Clinical Nutrition and GastroenterologySepsis Diagnosis and Treatment

Cited by 270

Timing and causes of death in septic shock

Daviaud, F., Grimaldi, D., Dechartres, A., Charpentier, J., Geri, G., Marin, N., Chiche, J.-D., Cariou, A., Mira, J.-P., & Pène, F. (2015) · Annals of Intensive Care

Sepsis Diagnosis and TreatmentAcute Kidney Injury Research

Cited by 234

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

Writing Committee for the REMAP-CAP Investigators, Abdelhady, H., Abdelrazik, M., Abdi, Z., Abdo, D., Abdulle, A., Abel, L., Abouzeenni, S., Abrahamson, G., Abusamra, Y., et al. (2021) · JAMA

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 212

Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: The multinational AID-ICU inception cohort study

Collet, M. O., Caballero, J., Sonneville, R., Bozza, F. A., Nydahl, P., Schandl, A., Wøien, H., Citerio, G., van den Boogaard, M., Hästbacka, J., et al. (2018) · Intensive Care Medicine

Intensive Care Unit Cognitive DisordersAnesthesia and Sedative Agents

Cited by 114